Israel’s medical cannabis reform may be detrimental to patients

Israel’s medical cannabis reform may be detrimental to patients, as many of them are to be left out of the new system if the reform passes.

The Ministry of Health in Israel is in the midst of conducting a medical cannabis reform which may prevent up to 15,000 patients from getting their medicine.

The reform was supposed to go into effect on April 1st, however, it has since been postponed as complications emerged.

Tikun Olam, the country’s largest medical cannabis supplier, have been forced to temporarily pause all operations and relocate their farm.

No more flower, just oil

Tikun Olam provided medical cannabis for nearly a third of the nations registered patients, as there’s little more than 38,000 of them at the moment.

Company officials voiced their concerns as the company won’t be able to supply more than a third of the country’s medical cannabis patients.

According to their statement, only the patients that are using oil will be able to continue filling out their prescription with Tikun Olam.

“Patients that need that certain type of treatment will go to different companies, because we didn’t have enough product to provide them. We are working as quickly as we can to get back to the production and up to regulation.”

Maayan Weisberg, foreign spokesperson for Tikun Olam

A Health Ministry spokesperson said that the Ministry believes everyone left without a valid prescription due to this issue should be able to renew it with a new producer in under 10 days.

The Land of Cannabis

Last week, Israel’s very own Cannatech conference made it’s fourth annual appearance. The main speaker of the conference was the former Prime Minister Ehud Barak.

In his speech, he revealed how the global cannabis market is worth around $17 billion at the moment, and is expected to grow to as much as $150 billion.

“Some 35 countries have already legalized cannabis to a certain extent, either for medical or sometimes even recreational use. Two-thirds of US states have approved medical cannabis; one-third [have approved] recreational use.”

Ehud Barak, former Prime Minister of Israel

Many important presentations found their way to the screens of the Cannatech conference, however one of the main events was the findings of Dr. Gal Meiri of Ben-Gurion University of the Negev, who shared the latest research on the effectiveness of medical cannabis in children with autism.

Categories News

Leave a Comment

Please confirm your age

Are you over 19 years of age (over 18 in Alberta and Quebec)?

By entering, you agree to Greencamp's Terms of Service and Privacy Policy.